Safety and efficacy of BI 655064, an antagonistic anti-CD40 antibody in rheumatoid arthritis (RA) patients

Authors
Category Primary study
JournalAnnals of the Rheumatic Diseases
Year 2016
This article has no abstract
Epistemonikos ID: 1d94e28a684827c04e647962f46fd8b14115346c
First added on: Mar 23, 2022